ZA200702066B - Halogenated benzmide derivatives - Google Patents

Halogenated benzmide derivatives

Info

Publication number: ZA200702066B
Authority: ZA; South Africa
Prior art keywords: benzmide; halogenated; derivatives; halogenated benzmide; benzmide derivatives
Prior art date: 2004-09-09

Application number

ZA200702066A

Other languages

English (en)

Inventor

Rossignol Jean Francois

Original Assignee

Romark Lab Lc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-09

Filing date

2005-09-06

Publication date

2008-08-27

2005-09-06 Application filed by Romark Lab Lc filed Critical Romark Lab Lc

2008-08-27 Publication of ZA200702066B publication Critical patent/ZA200702066B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Thiazole And Isothizaole Compounds (AREA)

ZA200702066A 2004-09-09 2005-09-06 Halogenated benzmide derivatives ZA200702066B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US60835404P	2004-09-09	2004-09-09

Publications (1)

Publication Number	Publication Date
ZA200702066B true ZA200702066B (en)	2008-08-27

Family

ID=36060542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200702066A ZA200702066B (en)	2004-09-09	2005-09-06	Halogenated benzmide derivatives

Country Status (25)

Country	Link
US (3)	US7285567B2 (xx)
EP (1)	EP1789040B1 (xx)
JP (1)	JP4998852B2 (xx)
KR (1)	KR101344984B1 (xx)
CN (1)	CN101035531B (xx)
AP (1)	AP2451A (xx)
AU (1)	AU2005285157B2 (xx)
BR (1)	BRPI0515089B8 (xx)
CA (1)	CA2580347C (xx)
CY (1)	CY1118689T1 (xx)
DK (1)	DK1789040T3 (xx)
EA (1)	EA012606B1 (xx)
ES (1)	ES2559672T3 (xx)
HR (1)	HRP20151439T1 (xx)
HU (1)	HUE026613T2 (xx)
IL (2)	IL181849A (xx)
ME (1)	ME02370B (xx)
MX (1)	MX2007002969A (xx)
PL (1)	PL1789040T3 (xx)
PT (1)	PT1789040E (xx)
RS (1)	RS54453B1 (xx)
SI (1)	SI1789040T1 (xx)
UA (1)	UA90864C2 (xx)
WO (1)	WO2006031566A2 (xx)
ZA (1)	ZA200702066B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101058292B1 (ko) *	2002-02-12	2011-08-22	글락소스미스클라인 엘엘씨	Ｐ38 억제제로 유용한 니코틴아미드 유도체
UA90864C2 (xx) *	2004-09-09	2010-06-10	Ромарк Лебораториз, Л.К.	Галогенізовані похідні бензаміду$галогенизированные производные бензамида
EP2047850A3 (en) *	2005-04-12	2009-07-29	Romark Laboratories, L.C.	Methods for treating diseases through inhibition of the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
CA2636527C (en) *	2006-01-09	2016-05-17	Romark Laboratories, L.C.	Viral hepatitis treatment
BRPI0815057B8 (pt)	2007-08-03	2021-05-25	Romark Laboratories Lc	composto, composição farmacêutica, e, uso de um composto
KR101697800B1 (ko)	2009-02-13	2017-01-18	로마크 레버러토리즈, 엘.씨.	니타족사니드의 서방성 제약 제형
EA021587B1 (ru)	2009-05-12	2015-07-30	РОМАРК ЛЭБОРЕТЕРИЗ Эл. Си.	Соединения галогеналкилгетероарилбензамида
EA030679B1 (ru)	2009-06-26	2018-09-28	РОМАРК ЛЭБОРЕТЕРИЗ Эл.Си.	Соединения и способы лечения гриппа
CN102335171B (zh) *	2010-07-27	2013-09-11	中国农业科学院上海兽医研究所	一类n-(2-噻唑)苯甲酰胺衍生物的应用
CN107096032A (zh)	2011-05-16	2017-08-29	罗马克实验室有限公司	在有需要的对象中刺激免疫应答的方法
WO2014052831A1 (en) *	2012-09-28	2014-04-03	Xavier University Of Louisiana	Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease
BR112017009651A2 (pt)	2014-11-11	2017-12-19	Romark Laboratories Lc	composto, composição farmacêutica, e, método para tratamento de uma infecção por protozoário intracelular, uma infecção viral ou um câncer.
PT3436074T (pt)	2016-03-31	2020-08-21	Romark Laboratories Lc	Compostos tiazolida para tratamento de infeções virais
SG11201808402RA (en)	2016-04-11	2018-10-30	Genfit	Methods of treatment for cholestatic and fibrotic diseases
US11173149B2 (en)	2017-04-18	2021-11-16	Romark Laboratories L.C.	Inhibition of protein disulfide-isomerase A3
EP4182304A1 (en)	2020-07-20	2023-05-24	Romark Laboratories, L.C.	Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine
JP2023538136A (ja)	2020-08-24	2023-09-06	ロマークラボラトリーズ，リミティドカンパニー	コロナウイルスに対するチアゾリドの利用
WO2022218239A1 (zh) *	2021-04-12	2022-10-20	杜心赟	新型噻唑类化合物及其制备方法和用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1276663A (en)	1968-12-24	1972-06-07	Ici Ltd	Stimulation of plant growth
ZA712295B (en) *	1970-04-15	1972-01-26	Shell Int Research	Fungicidal compounds
GB1437800A (en)	1973-08-08	1976-06-03	Phavic Sprl	Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en)	1978-12-07	1982-02-09	Rossignol Jean F	Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
JPS60205454A (ja) *	1984-03-29	1985-10-17	Mitsubishi Paper Mills Ltd	電子写真感光体
US5169846A (en)	1989-10-12	1992-12-08	Crooks Michael J	Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
US5578612A (en) *	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
US5578621A (en)	1994-09-08	1996-11-26	Romark Lab Lc	Benzamide derivatives
US5387598A (en) *	1994-04-13	1995-02-07	Rossignol; Jean-Francois	Composition and galenic formulation suitable for combatting affections of the lower abdomen
DK0755386T3 (da)	1994-04-13	2002-08-26	Romark Lab Lc	Benzamid-derivater, sammensætninger indeholdende nævnte derivat og anvendelse deraf
MX9604483A (es)	1994-09-08	1998-02-28	Jean-Francois Rossignol	Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
US5856348A (en) *	1994-09-08	1999-01-05	Romark Laboratories, L.C.	Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US5859038A (en)	1994-09-08	1999-01-12	Romark Laboratories, L.C.	Method for treatment of helicobacter pylori infections
US5965590A (en) *	1994-09-08	1999-10-12	Romark Lab Lc	Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US5968961A (en) *	1997-05-07	1999-10-19	Romark Laboratories, L.C.	Pharmaceutical compositions of tizoxanide and nitazoxanide
DE19528046A1 (de) *	1994-11-21	1996-05-23	Bayer Ag	Triazolyl-Derivate
US5935591A (en)	1998-01-15	1999-08-10	Romark Laboratories, L.C.	Method for treatment of equine protozoal myeloencephalitis with thiazolides
GB9823871D0 (en) *	1998-10-30	1998-12-23	Pharmacia & Upjohn Spa	2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
KR20020089493A (ko) *	2000-04-28	2002-11-29	상꾜 가부시키가이샤	ＰＰＡＲγ모듈레이터
WO2002005675A1 (en) *	2000-07-14	2002-01-24	Breed Automotive Technology, Inc.	Illuminated buckle and tongue
UA82827C2 (en) *	2000-12-18	2008-05-26		Inhibitors against the production and release of inflammatory cytokines
JP2003064056A (ja) *	2001-08-27	2003-03-05	Sankyo Co Ltd	アミド誘導体
WO2003035602A1 (en) *	2001-10-25	2003-05-01	Sankyo Company, Limited	Lipid modulators
CN1658872B (zh) *	2002-06-06	2010-09-22	株式会社医药分子设计研究所	抗过敏药
US6737382B1 (en) *	2002-10-23	2004-05-18	Nippon Soda Co. Ltd.	Insecticidal aminothiazole derivatives
CN1933839A (zh) *	2004-01-23	2007-03-21	安进公司	化合物和使用方法
UA90864C2 (xx) *	2004-09-09	2010-06-10	Ромарк Лебораториз, Л.К.	Галогенізовані похідні бензаміду$галогенизированные производные бензамида

2005
- 2005-06-09 UA UAA200702713A patent/UA90864C2/ru unknown
- 2005-09-06 RS RS20160058A patent/RS54453B1/sr unknown
- 2005-09-06 BR BRPI0515089A patent/BRPI0515089B8/pt not_active IP Right Cessation
- 2005-09-06 WO PCT/US2005/031868 patent/WO2006031566A2/en not_active Ceased
- 2005-09-06 HR HRP20151439TT patent/HRP20151439T1/hr unknown
- 2005-09-06 CN CN2005800338784A patent/CN101035531B/zh not_active Expired - Fee Related
- 2005-09-06 PT PT58001421T patent/PT1789040E/pt unknown
- 2005-09-06 JP JP2007531304A patent/JP4998852B2/ja not_active Expired - Fee Related
- 2005-09-06 ME MEP-2016-7A patent/ME02370B/me unknown
- 2005-09-06 CA CA2580347A patent/CA2580347C/en not_active Expired - Fee Related
- 2005-09-06 ZA ZA200702066A patent/ZA200702066B/xx unknown
- 2005-09-06 AU AU2005285157A patent/AU2005285157B2/en not_active Ceased
- 2005-09-06 EA EA200700432A patent/EA012606B1/ru not_active IP Right Cessation
- 2005-09-06 DK DK05800142.1T patent/DK1789040T3/en active
- 2005-09-06 AP AP2007003950A patent/AP2451A/xx active
- 2005-09-06 MX MX2007002969A patent/MX2007002969A/es active IP Right Grant
- 2005-09-06 HU HUE05800142A patent/HUE026613T2/hu unknown
- 2005-09-06 SI SI200532034T patent/SI1789040T1/sl unknown
- 2005-09-06 PL PL05800142T patent/PL1789040T3/pl unknown
- 2005-09-06 EP EP05800142.1A patent/EP1789040B1/en not_active Expired - Lifetime
- 2005-09-06 US US11/221,256 patent/US7285567B2/en not_active Expired - Lifetime
- 2005-09-06 ES ES05800142.1T patent/ES2559672T3/es not_active Expired - Lifetime
2007
- 2007-03-11 IL IL181849A patent/IL181849A/en not_active IP Right Cessation
- 2007-03-29 KR KR1020077007159A patent/KR101344984B1/ko not_active Expired - Fee Related
- 2007-10-01 US US11/865,532 patent/US7645783B2/en active Active
- 2007-10-01 US US11/865,541 patent/US7550493B2/en not_active Expired - Lifetime
2009
- 2009-12-29 IL IL203061A patent/IL203061A/en active IP Right Grant
2016
- 2016-01-20 CY CY20161100061T patent/CY1118689T1/el unknown

Also Published As

Publication number	Publication date
EP1789040A4 (en)	2009-09-02
ME02370B (me)	2016-06-20
JP4998852B2 (ja)	2012-08-15
AU2005285157A1 (en)	2006-03-23
BRPI0515089B8 (pt)	2021-05-25
CY1118689T1 (el)	2017-07-12
KR20070052330A (ko)	2007-05-21
ES2559672T3 (es)	2016-02-15
BRPI0515089B1 (pt)	2019-07-16
CA2580347C (en)	2013-12-10
US20060089396A1 (en)	2006-04-27
SI1789040T1 (sl)	2016-02-29
IL181849A0 (en)	2007-07-04
MX2007002969A (es)	2008-02-15
UA90864C2 (xx)	2010-06-10
RS54453B1 (sr)	2016-06-30
PL1789040T3 (pl)	2016-04-29
CA2580347A1 (en)	2006-03-23
WO2006031566A3 (en)	2006-06-08
EP1789040A2 (en)	2007-05-30
IL181849A (en)	2013-11-28
US7645783B2 (en)	2010-01-12
JP2008512474A (ja)	2008-04-24
US7550493B2 (en)	2009-06-23
US20080097106A1 (en)	2008-04-24
AU2005285157B2 (en)	2009-07-16
DK1789040T3 (en)	2016-02-01
WO2006031566A2 (en)	2006-03-23
HK1106139A1 (zh)	2008-03-07
IL203061A (en)	2013-04-30
CN101035531B (zh)	2013-01-02
EP1789040B1 (en)	2015-12-23
US20080096941A1 (en)	2008-04-24
AP2007003950A0 (en)	2007-04-30
EA012606B1 (ru)	2009-10-30
EA200700432A1 (ru)	2007-10-26
CN101035531A (zh)	2007-09-12
KR101344984B1 (ko)	2013-12-24
US7285567B2 (en)	2007-10-23
BRPI0515089A (pt)	2008-07-08
PT1789040E (pt)	2016-02-19
HRP20151439T1 (hr)	2016-02-12
HUE026613T2 (hu)	2016-06-28
AP2451A (en)	2012-08-31

Publication	Publication Date	Title
TWI369356B (en)	2012-08-01	Tetrahydropyridoindole derivatives
IL180481A0 (en)	2007-06-03	Aryl-pyridine derivatives
ZA200610102B (en)	2008-08-27	Pyrrazolo-pyrimidine derivatives
IL180331A0 (en)	2007-07-04	3-carbamoyl - 2 - pyridone derivative
IL181849A0 (en)	2007-07-04	Halogenated benzamide derivatives
IL182585A0 (en)	2007-07-24	Imidazo-benzodiazepine derivatives
IL183140A0 (en)	2007-09-20	Substituted benzoquinolizine derivatives
IL183142A0 (en)	2007-09-20	New pyridothienopyrimidine derivatives
IL179603A0 (en)	2007-05-15	Pyrrolopyridine derivatives
AP2074A (en)	2009-12-14	New 4-benzylidene-piperidin derivatives
IL183141A0 (en)	2007-09-20	New pyridothienopyrimidine derivatives
GB0414272D0 (en)	2004-07-28	OsK1 derivatives
IL177204A0 (en)	2006-12-10	Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives
IL179444A0 (en)	2007-05-15	4-phenyl-pyrimidine-2-carbonitrile derivatives
TWI346109B (en)	2011-08-01	4-amino-5-cyanopyrimidine derivatives
IL182001A0 (en)	2007-07-04	2-acylaminothiazole derivatives
ZA200609864B (en)	2008-08-27	Pyrrolopyridine derivatives
GB0422397D0 (en)	2004-11-10	3-Cyano-Quinoline derivatives
GB0405905D0 (en)	2004-04-21	Azaquinazoline derivatives
HUP0402371A2 (en)	2006-09-28	Novel 125-i-labeled amino-quinoline derivatives
GB0418566D0 (en)	2004-09-22	Tropane derivatives